March 11 Quick Takes: PDL, Kala, InnoCare, LifeSci, BioSight, BillionToOne, SEC

PDL to dissolve by year-end
PDL BioPharma Inc. (NASDAQ:PDLI) said it will cease operations and seek to sell the company or monetize its assets. PDL acquires commercial-stage pharmaceutical assets and late clinical stage products. On Monday, the company said VP, Chief Accounting Officer and acting CFO

Read the full 454 word article

How to gain access

Continue reading with a
two-week free trial.